Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

23:37 EDT 27th September 2016 | BioPortfolio

Showing News Articles 1–25 of 640,000+

Tuesday 27th September 2016

China's CANbridge Starts Taiwan Trial of Novel Brain Cancer Drug

CANbridge Life Sciences, a Beijing in-licensing biopharma, announced the first dosing of Taiwan Phase I/II trial of its lead candidate, CAN-008, a treatment for newly-diagnosed glioblastoma multiforme (GBM). An immunotherapy, CAN-008 inhibits the CD95 ligand, a member of the tumor necrosis factor family, with the goal of restoring the immune system’s anti-tumor response and inhibiting t...

China BioPharma Capital Invests in Quantapore, a Sequencing Device Maker

China BioPharma Capital led a Series C financing in Quantapore, a Bay Area sequencing device company. The financial details were not disclosed. China BioPharma Capital is a life science venture capital fund, based in Hong Kong, whose $50 million in initial capital came entirely from Chongqing Lummy Pharma. The fund is run by TVM Capital Life, a Munich-Montreal-Hong Kong investment firm, and plans ...

ME affects four times as many women as men. Is that why we’re still disbelieved? | ‘Comment is free’, The Guardian | 27 September 2016

From The Guardian ‘Comment is free’ section, 27 September 2016. Words by Nathalie Wright (pictured). Today friends and families of people with myalgic encephalopathy (ME) are taking to the streets...

Maryland group attacks high cost of prescription drugs

With EpiPens and other prescription drugs rising in cost, families who desperately need them but do not have health insurance are bearing a huge financial burden, according to community advocates. The Maryland Citizens' Health Initiative, a coalition of more than 1,200 religious, labor, business and policy groups seeking quality and affordable health care, wants the state legislature to addres...

[Correspondence] The fight against rabies: the Middle East needs to step up its game

The tenth World Rabies Day will be celebrated across the globe on Sept 28, 2016. This day marks the anniversary of the death of Louis Pasteur, a French chemist and microbiologist who developed the very first rabies vaccine. Each year, the day aims to raise awareness about rabies prevention.

Is there an ROI on KOLs?

Can you measure return on investment (ROI) from compliant, patient-centred skills training for key opinion leaders?

[Comment] Understanding brain development: a major step

A landmark report by Trygve Bakken and colleagues1 provides, for the first time, a comprehensive, high-resolution, four-dimensional map of gene expression from early gestation to young adulthood in the whole brain of a non-human primate (rhesus monkey). This tour-de-force is of central relevance to our understanding of human brain development because the rhesus monkey brain is phylogenetically clo...

Pelican raises awareness of diabetes

Pelican BioThermal is a partner in an exciting global cycling challenge, which is helping raise awareness about diabetes. The post Pelican raises awareness of diabetes appeared first on PharmaAsia.

Macmillan Cancer Support warn of strain on "sandwich generation" of carers

Around 110,000 people in the UK are caring for a parent with cancer, which could include everything from taking care of finances to washing and dressing them, while also looking after their own children, according to a new report launched today by...

Cancer symptom awareness linked to chance of survival

IN REGIONS where cancer survival is poorer, people on average have lower awareness of cancer symptoms, according to new findings published in the British Journal of Cancer. Researchers also found that general awareness of cancer symptoms varies greatly...

Agilent launches panel for fast FISH testing on Dako Omnis in lung cancer

New lung cancer panel enables acceleration of routine, automated testing in pathology laboratories. The post Agilent launches panel for fast FISH testing on Dako Omnis in lung cancer appeared first on PharmaAsia.

Australian CF drug approved in Russia

Cystic fibrosis drug Bronchitol, from pharmaceutical research company Pharmaxis (ASX:PXS), has been approved for marketing in Russia for the treatment of both paediatric and adult CF patients. The drug is the first medicine to be processed under new Russian laws to provide patients access to innovative medicines, announced in January 2016. Bronchitol is a precision spray-dried form of mannitol, d...

Sartorius Stedim Biotech Sartocon Slice 50 ECO crossflow filter

Sartorius Stedim Biotech has announced the small-scale Sartocon Slice 50 ECO crossflow device. The crossflow filter has been specially designed for water-based protein solutions with viscosities below 3 cp. The crossflow cassette can typically be used in biotech applications, such as filtration of IgG, blood factors and peptides, especially involving membrane screening and small-volume process de...

Titratable sleep apnoea device cleared by FDA

Australian medical device company Oventus Medical (ASX:OVN) has received clearance from the US FDA for the O2Vent T device, an oral appliance intended to alleviate snoring and obstructive sleep apnoea (OSA). The clearance allows Oventus to launch into the US, where it will target the 12–18 million US adults currently estimated to have sleep apnoea. The product is a 3D-printed titanium mandibula...

Nanoparticles get in shape for drug delivery

Polymeric nanoparticles are expected to play a vital role in the future of medicine, carrying drugs to exactly where they are needed to help attack and kill cancer cells. Now, UNSW researchers have answered a longstanding question that could lead to better drug delivery vehicles: how does a nanoparticle’s shape affect its voyage through the cell? In a study published in the journal Nature Nanot...

Rapidscale Hires Chris Moreira To Head Up Channel Sales For The Western Region

Chris is a proven leader, joining RapidScale after his service for the United States Marines as an MV-22 Osprey Pilot and Flight Operations Manager. (PRWEB) September 27, 2016 RapidScale, a leader in managed cloud services, welcomes Chris Moreira to the team as Channel Manager, West Region. Chris is based out of RapidScale’s corporate headquarters in Irvine, Calif. His responsibilities include ...

Here's How To Punch Martin Shkreli In The Face

Here's something that may actually be priced at free market value. Former hedge fund manager and Turing Pharmaceutical CEO Martin Shkreli is now auctioning off an opportunity to punch him in the face.

Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy

Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain

John Reites Joins THREAD Research as Chief Product Officer and Partner

TUSTIN, Calif., Sept. 27, 2016 /PRNewswire/ -- THREAD Research, a leader in remote patient research and care leveraging Apple HealthKit, ResearchKit and CareKit, welcomes life sciences veteran and digital health innovator, John Reites, to its executive suite. Photo - http://photos.prnewswire.com/prnh/20160927/412618 Reites joins the company as Chief Product Officer and Partner, bringing d...

When Drug Reviewers Leave The FDA, They Often Work For Pharma

Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.

From FDA expert to biotech insider: The drug industry thrives on the revolving door

A study found that more than half of the FDA's hematology-oncology experts between 2001 and 2010 went on to work for the biopharmaceutical industry.

CSA Group Opens Highly Advanced Electro - Medical Laboratory in Seoul

 - Part of Healthcare Expansion and Global Service Offerings - SEOUL, Sept. 27, 2016 /PRNewswire/ - CSA Group, a global provider of testing and certification services and a leading standards development organization, today announced the opening of its new medical laboratory in Songpa-gu, Seoul, specializing in testing and certification services for electro-medical and laboratory equip...

Successful completion of regulatory consultations to progress filgotinib to Phase 3 in inflammatory bowel disease

    Global program to start in Q4'16 DIVERSITY Phase 3 study in Crohn's disease SELECTION Phase 2b/3 study in ulcerative colitis 100 mg and 200 mg once daily doses included

Lung cancer: Stage III NSCLC — is it time to centralize care?

Eaton et al. report a very strong association between institutional clinical trial accrual volume and the survival of patients with stage III NSCLC. The observed volume effect might have been exaggerated by artefact. More work is required to quantify the volume effect and understand its causes, before rushing to centralize care.


Quick Search
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.